RUEY JIIN YU
Acupuncture in Chalfont, PA
License number
Pennsylvania AK000056L
Category
Medicine
Type
Acupuncturist
Address
Address
Chalfont, PA 18914
Personal information
See more information about RUEY JIIN YU at radaris.comName
Address
Phone
4 Lindenwald Ter, Ambler, PA 19002
655 Stump Rd, Chalfont, PA 18914
Line Lexington, PA
13 Lakeview Dr, Newfoundland, PA 18445
13 B Lakeview Dr, Newfoundland, PA 18445
Professional information
See more information about RUEY JIIN YU at trustoria.com
N-(Phosphonoalkyl)-Amino Acids, Derivatives Thereof And Compositions And Methods Of Use
N-(Phosphonoalkyl)-Amino Acids, Derivatives Thereof And Compositions And Methods Of Use
US Patent:
2010024, Sep 30, 2010
Filed:
Jun 16, 2010
Appl. No.:
12/816514
Inventors:
Ruey J. Yu - Chalfont PA, US
Eugene J. Van Scott - Abington PA, US
Eugene J. Van Scott - Abington PA, US
International Classification:
A61K 31/662, C07F 9/38, A61P 31/12, A61P 31/10, A61P 31/04, A61P 17/00, A61P 1/08, A61P 29/00, A61Q 15/00, A61P 25/22, A61P 25/24, A61Q 17/04, A61P 17/12, A61Q 19/00, A61P 17/02, C07F 9/572, A61K 31/675, C07K 5/037, A61K 38/06, A61K 8/55, A61K 39/395, A61K 38/38, A61K 38/20, A61K 38/48, A61K 33/06, A61K 31/7048
US Classification:
424 59, 562 17, 514114, 424 65, 424 701, 548413, 514 91, 530331, 514 219, 4241331, 4241421, 514 152, 424 852, 424 9464, 424685, 514 29
Abstract:
The present invention relates to an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof, the N-(phosphonoalkyl)-amino acid, related compound or derivative thereof being in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, other than N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine. Also included is a composition including an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, and a cosmetically or pharmaceutically acceptable vehicle for topical or systemic administration to a mammalian subject, as well as a method of administering an effective amount of such a composition for alleviating or improving a condition, disorder, symptom or syndrome associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system.
N-(Phosphonoalkyl)-Amino Acids, Derivatives Thereof And Compositions And Methods Of Use
N-(Phosphonoalkyl)-Amino Acids, Derivatives Thereof And Compositions And Methods Of Use
US Patent:
7776844, Aug 17, 2010
Filed:
Apr 23, 2009
Appl. No.:
12/428906
Inventors:
Ruey J. Yu - Chalfont PA, US
Eugene J. Van Scott - Abington PA, US
Eugene J. Van Scott - Abington PA, US
International Classification:
A61K 31/66
US Classification:
514114, 514399
Abstract:
The present invention relates to an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof, the N-(phosphonoalkyl)-amino acid, related compound or derivative thereof being in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, other than N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine. Also included is a composition including an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, and a cosmetically or pharmaceutically acceptable vehicle for topical or systemic administration to a mammalian subject, as well as a method of administering an effective amount of such a composition for alleviating or improving a condition, disorder, symptom or syndrome associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system.
Topical Treatment Of Dermatological Disorders Associated With Reactive Or Dilated Blood Vessels
Topical Treatment Of Dermatological Disorders Associated With Reactive Or Dilated Blood Vessels
US Patent:
2004022, Nov 4, 2004
Filed:
Apr 2, 2004
Appl. No.:
10/817479
Inventors:
Ruey Yu - Chalfont PA, US
Eugene Van Scott - Abington PA, US
Eugene Van Scott - Abington PA, US
International Classification:
A61K031/366, A61K031/19
US Classification:
514/460000, 514/557000
Abstract:
The invention provides a method of topically treating a dermatological disorder. The method includes topically applying a therapeutically effective amount of a cosmetic or dermatological composition to an affected area of the skin. The composition includes at least one compound that is (i) a polyhydroxy-aldonic acid, (ii) a polyhydroxy-aldonic lactone, (iii) a polyhydroxy-alduronic acid, (iv) a polyhydroxy-alduronic lactone, (v) a polyhydroxy-aldaric acid; (vi) a polyhydroxy-aldaric lactone, and (vii) an organic acid lactone having two or more hydroxyl or ketohydroxyl groups. The dermatological disorder treated is one associated with reactive or dilated blood vessels. Also included in the invention are methods of treating dermatological disorders associated with reactive blood vessels that include topical application of a therapeutically effective amount of a composition. The composition includes at least one compound selected from a compound represented by formula (I):
by formula (II):
and by formula (III)
and a lactone derived from an organic acid having two or more hydroxyl or ketohydroxyl groups.
Anti-Odor Compositions And Therapeutic Use
Anti-Odor Compositions And Therapeutic Use
US Patent:
2006025, Nov 9, 2006
Filed:
May 3, 2006
Appl. No.:
11/381374
Inventors:
Ruey Yu - Chalfont PA, US
Eugene Van Scott - Abington PA, US
Eugene Van Scott - Abington PA, US
International Classification:
A61L 9/00, A61K 8/46, A61K 8/49
US Classification:
424065000, 424076200
Abstract:
This application discloses a composition comprising a malodor compound and an anti-odor ingredient effective for reducing the presence or production of malodor. The composition may be topically applied to a subject and is useful for cosmetic conditions, pharmaceutical indications, or other objectives.
N-Acetyl Aldosamines, N-Acetylamino Acids And Related N-Acetyl Compounds And Their Topical Use
N-Acetyl Aldosamines, N-Acetylamino Acids And Related N-Acetyl Compounds And Their Topical Use
US Patent:
RE41339, May 18, 2010
Filed:
Nov 1, 2006
Appl. No.:
11/590898
Inventors:
Ruey J. Yu - Chalfont PA, US
Eugene J. Van Scott - Abington PA, US
Eugene J. Van Scott - Abington PA, US
Assignee:
Tristrata, Inc. - Wilmington DE
International Classification:
A61K 8/02
US Classification:
424401, 514 2, 514554, 514557, 514574, 514844, 514847
Abstract:
Compositions comprising N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl compounds are useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors. N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl composition may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
Composition And Method For Topical Treatment Of Tar-Responsive Dermatological Disorders
Composition And Method For Topical Treatment Of Tar-Responsive Dermatological Disorders
US Patent:
2007020, Sep 6, 2007
Filed:
Feb 28, 2007
Appl. No.:
11/680227
Inventors:
Ruey J. Yu - Chalfont PA, US
Eugene J. Van Scott - Abington PA, US
Yaling Lee - Plainsboro NJ, US
Eugene J. Van Scott - Abington PA, US
Yaling Lee - Plainsboro NJ, US
Assignee:
TriStrata, Inc. - Wilmington DE
International Classification:
A61K 36/00
US Classification:
4247251
Abstract:
The present invention relates to a composition including a wax and a therapeutically effective amount of tar for topical treatment of a tar-responsive dermatological disorder, the composition being in liquid or light gel form when at a temperature selected from room temperature and a temperature of skin of a mammal upon application of the composition to the skin of the mammal. The invention also relates to a method of treating a tar-responsive dermatological disorder by topically applying the composition to skin of a mammal, preferably a human, that is involved with the disorder.
Bioavailability And Improved Delivery Of Alkaline Pharmaceutical Drugs
Bioavailability And Improved Delivery Of Alkaline Pharmaceutical Drugs
US Patent:
2004021, Oct 28, 2004
Filed:
Mar 4, 2004
Appl. No.:
10/792273
Inventors:
Ruey Yu - Chalfont PA, US
Eugene Van Scott - Abington PA, US
Eugene Van Scott - Abington PA, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
Embodiments of the invention relate to a composition, a process of making the composition, and to the use of the composition. The compositions include a molecular complex formed between an alkaline pharmaceutical drug and at least one selected from a hydroxyacid, a polyhydroxy acid, a related acid, a lactone, or combinations thereof. The compositions provide improved bioavailability and improved delivery of the drug into the cutaneous tissues.
Oligosaccharide Aldonic Acids And Their Topical Use
Oligosaccharide Aldonic Acids And Their Topical Use
US Patent:
2011009, Apr 21, 2011
Filed:
Dec 23, 2010
Appl. No.:
12/977317
Inventors:
Ruey J. Yu - Chalfont PA, US
Eugene J. Van Scott - Abington PA, US
Eugene J. Van Scott - Abington PA, US
International Classification:
A61Q 15/00, A61K 31/7016, A61K 8/60, A61K 38/22, A61K 8/64, A61K 38/05, A61K 38/06, A61K 38/00, A61K 8/67, A61P 17/00, A61P 29/00, A61Q 19/04, A61P 31/00
US Classification:
424 65, 514 53, 514 97, 514 186, 514 188, 514 207, 514 219, 514 2191, 514 11
Abstract:
Methods for using compositions comprising oligosaccharide aldonic acids for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including those associated with intrinsic and/or extrinsic aging, as well as with changes or damage caused by extrinsic factors; general care, as well as treatment and prevention of diseases and conditions, of the oral, and vaginal mucosa; for general oral care, as well as treatment and prevention of oral and gum diseases; and for wound healing of the skin. Methods may comprise using compositions comprising oligosaccharide aldonic acids and additional cosmetic, pharmaceutical or other topical agents to enhance or create synergetic effects.
N-Acetyl Aldosamines, N-Acetylamino Acids And Related N-Acetyl Compounds And Their Topical Use
N-Acetyl Aldosamines, N-Acetylamino Acids And Related N-Acetyl Compounds And Their Topical Use
US Patent:
RE42902, Nov 8, 2011
Filed:
Aug 5, 2009
Appl. No.:
12/536209
Inventors:
Ruey J. Yu - Chalfont PA, US
Eugene J. Van Scott - Abington PA, US
Eugene J. Van Scott - Abington PA, US
Assignee:
Tristrata, Inc. - Wilmington DE
International Classification:
A61K 8/02
US Classification:
424401, 514 2, 514554, 514557, 514574, 514844, 514847
Abstract:
Compositions comprising N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl compounds are useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors. N-acetyl-aldosamines, N-acetylamino acids, and related N-acetyl composition may further comprise a cosmetic, pharmaceutical or other topical agent to enhance or create synergetic effects.
Bioavailability And Improved Delivery Of Acidic Pharmaceutical Drugs
Bioavailability And Improved Delivery Of Acidic Pharmaceutical Drugs
US Patent:
2004022, Nov 4, 2004
Filed:
Mar 16, 2004
Appl. No.:
10/801134
Inventors:
Ruey Yu - Chalfont PA, US
Eugene Van Scott - Abington PA, US
Eugene Van Scott - Abington PA, US
International Classification:
A61K031/205
US Classification:
514/554000
Abstract:
Embodiments of the invention relate to a composition, a process of making the composition, and to the use of the composition. The compositions include a molecular complex formed between an acidic pharmaceutical drug and at least one functional substance. The compositions provide improved bioavailability and improved delivery of the drug into the cutaneous tissues.